Cognoptix

About:

Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.

Top Investors: LaunchPad Venture, New York Angels, Alopexx, Boston Harbor Angels, Inventages Venture Capital Investment Inc.

Description:

Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment. The company was founded in 2001 and headquartered in Marlborough, Massachusetts.

Total Funding Amount:

$46.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Marlborough, Massachusetts, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)cognoptix.com

Founders:

Lee Goldstein, Leo Chylack

Number of Employees:

1-10

Last Funding Date:

2020-09-28

IPO Status:

Private

Industries: